Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 371

1.

Acellular pertussis vaccine safety and efficacy in children, adolescents and adults.

Casey JR, Pichichero ME.

Drugs. 2005;65(10):1367-89. Review.

PMID:
15977969
[PubMed - indexed for MEDLINE]
2.

Acellular pertussis vaccines for adolescents.

Pichichero ME, Casey JR.

Pediatr Infect Dis J. 2005 Jun;24(6 Suppl):S117-26. Review.

PMID:
15931139
[PubMed - indexed for MEDLINE]
3.

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A; Stage III Working Group.

Pediatrics. 2001 Nov;108(5):E81.

PMID:
11694665
[PubMed - indexed for MEDLINE]
4.

A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.

Pichichero ME, Deloria MA, Rennels MB, Anderson EL, Edwards KM, Decker MD, Englund JA, Steinhoff MC, Deforest A, Meade BD.

Pediatrics. 1997 Nov;100(5):772-88.

PMID:
9346976
[PubMed - indexed for MEDLINE]
5.

Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children.

Pichichero ME, Edwards KM, Anderson EL, Rennels MB, Englund JA, Yerg DE, Blackwelder WC, Jansen DL, Meade BD.

Pediatrics. 2000 Jan;105(1):e11.

PMID:
10617748
[PubMed - indexed for MEDLINE]
6.

Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.

America Academy of Pediatrics Commitee on Infectious Diseases.

Pediatrics. 2006 Mar;117(3):965-78. Epub 2005 Dec 28.

PMID:
16382131
[PubMed - indexed for MEDLINE]
Free Article
8.

Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).

Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, Mijalski CM, Tiwari T, Weston EJ, Cohn AC, Srivastava PU, Moran JS, Schwartz B, Murphy TV; Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34.

PMID:
16557217
[PubMed - indexed for MEDLINE]
Free Article
9.

A modified vaccine reduces the rate of large injection site reactions to the preschool booster dose of diphtheria-tetanus-acellular pertussis vaccine: results of a randomized, controlled trial.

Scheifele DW, Halperin SA, Ochnio JJ, Ferguson AC, Skowronski DM.

Pediatr Infect Dis J. 2005 Dec;24(12):1059-66. Erratum in: Pediatr Infect Dis J. 2006 Mar;25(3):229.

PMID:
16371866
[PubMed - indexed for MEDLINE]
10.

Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group.

Cassone A, Ausiello CM, Urbani F, Lande R, Giuliano M, La Sala A, Piscitelli A, Salmaso S.

Arch Pediatr Adolesc Med. 1997 Mar;151(3):283-9.

PMID:
9080938
[PubMed - indexed for MEDLINE]
11.

Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.

Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR; Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov.

Pediatrics. 2005 Aug;116(2):e285-94.

PMID:
16061582
[PubMed - indexed for MEDLINE]
Free Article
12.

Antibody response and reactions to completion of a four-dose series with a two- or three-component acellular pertussis vaccine compared to whole cell pertussis vaccine.

Pichichero ME, Green JL, Francis AB, Marsocci SM, Murphy AM, Buscarino C.

Scand J Infect Dis. 1996;28(2):159-63.

PMID:
8792483
[PubMed - indexed for MEDLINE]
13.

Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.

Black S, Friedland LR, Ensor K, Weston WM, Howe B, Klein NP.

Pediatr Infect Dis J. 2008 Apr;27(4):341-6. doi: 10.1097/INF.0b013e3181616180.

PMID:
18316985
[PubMed - indexed for MEDLINE]
14.

Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.

Pichichero ME, Casey JR, Francis AB, Marsocci SM, Murphy M, Hoeger W, Cleary C.

Clin Pediatr (Phila). 2006 Sep;45(7):613-20.

PMID:
16928838
[PubMed - indexed for MEDLINE]
15.

A fully liquid diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis--Haemophilus influenzae type b conjugate vaccine: immunogenicity and safety of primary vaccination in Taiwanese infants.

Lin TY, Wang YH, Chang LY, Huang YC, Kao HT, Lin PY, Lu HK, Chavand P, Ortiz E.

Int J Infect Dis. 2007 Mar;11(2):129-36. Epub 2006 Jun 9.

PMID:
16762579
[PubMed - indexed for MEDLINE]
Free Article
16.
17.

Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults.

Scott LJ.

BioDrugs. 2010 Dec 1;24(6):387-406. doi: 10.2165/11206000-000000000-00000. Review.

PMID:
21043546
[PubMed - indexed for MEDLINE]
18.

Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults.

Pichichero ME, Rennels MB, Edwards KM, Blatter MM, Marshall GS, Bologa M, Wang E, Mills E.

JAMA. 2005 Jun 22;293(24):3003-11. Epub 2005 Jun 2. Erratum in: JAMA. 2005 Dec 28;294(24):3092.

PMID:
15933223
[PubMed - indexed for MEDLINE]
19.

One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine.

Lin TY, Wang YH, Huang YC, Chiu CH, Lin PY, Chen CJ, Chavand P, Ortiz E.

Int J Infect Dis. 2007 Nov;11(6):488-95. Epub 2007 Mar 8.

PMID:
17349809
[PubMed - indexed for MEDLINE]
Free Article
20.

Cellular immunity as a potential cause of local reactions to booster vaccination with diphtheria and tetanus toxoids and acellular pertussis antigens.

Scheifele DW, Ochnio JJ, Halperin SA.

Pediatr Infect Dis J. 2009 Nov;28(11):985-9. doi: 10.1097/INF.0b013e3181a9cc2a.

PMID:
19755930
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk